ifosfamide has been researched along with Kidney Failure in 9 studies
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To explore the effect of high-dose ifosfamide in first-line treatment for patients < or = 40 years of age with nonmetastatic osteosarcoma of the extremity." | 9.11 | Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. ( Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T, 2005) |
| "Although chemotherapy for advanced bladder cancer has historically been based on cisplatin-based combination regimens, the limitations of these regimens both in terms of efficacy and toxicity are now widely appreciated." | 6.39 | Ifosfamide in the treatment of bladder cancer. ( Roth, BJ, 1996) |
| "To explore the effect of high-dose ifosfamide in first-line treatment for patients < or = 40 years of age with nonmetastatic osteosarcoma of the extremity." | 5.11 | Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. ( Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T, 2005) |
| "The purpose of this study was to make evidence-based recommendations regarding the mode, dosage and schedule of delivery of concomitant mesna (sodium-2-mercaptoethanesulfonate) to protect against ifosfamide-induced uroepithelial toxicity." | 2.40 | Use of mesna to prevent ifosfamide-induced urotoxicity. ( Moore, MJ; Siu, LL, 1998) |
| "Although chemotherapy for advanced bladder cancer has historically been based on cisplatin-based combination regimens, the limitations of these regimens both in terms of efficacy and toxicity are now widely appreciated." | 2.39 | Ifosfamide in the treatment of bladder cancer. ( Roth, BJ, 1996) |
| " There was no compelling evidence for increased toxicity of doxorubicin when given at 100% versus 50% dosing (full dose: 20 mg/m(2) day x 3), but the number of patients analyzed was small." | 1.35 | Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group. ( Breslow, NE; Feusner, JH; Green, DM; Norkool, PA; Ritchey, ML; Takashima, JR, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Khandelwal, P | 1 |
| Govindarajan, S | 1 |
| Bagga, A | 1 |
| Arjmand, A | 3 |
| Mashhadi, M | 3 |
| Kaveh, A | 3 |
| Kamranfar, F | 3 |
| Seydi, E | 3 |
| Pourahmad, J | 3 |
| Yin, ZM | 1 |
| Yu, AJ | 1 |
| Wu, MJ | 1 |
| Fang, J | 1 |
| Liu, LF | 1 |
| Zhu, JQ | 1 |
| Yu, H | 1 |
| Ferrari, S | 1 |
| Smeland, S | 1 |
| Mercuri, M | 1 |
| Bertoni, F | 1 |
| Longhi, A | 1 |
| Ruggieri, P | 1 |
| Alvegard, TA | 1 |
| Picci, P | 1 |
| Capanna, R | 1 |
| Bernini, G | 1 |
| Müller, C | 1 |
| Tienghi, A | 1 |
| Wiebe, T | 1 |
| Comandone, A | 1 |
| Böhling, T | 1 |
| Del Prever, AB | 1 |
| Brosjö, O | 1 |
| Bacci, G | 1 |
| Saeter, G | 1 |
| Schlondorff, JS | 1 |
| Mendez, GP | 1 |
| Rennke, HG | 1 |
| Magee, CC | 1 |
| Feusner, JH | 1 |
| Ritchey, ML | 1 |
| Norkool, PA | 1 |
| Takashima, JR | 1 |
| Breslow, NE | 1 |
| Green, DM | 1 |
| Roth, BJ | 1 |
| Liubimova, NV | 1 |
| Kumykova, ZhKh | 1 |
| Kushlinskiĭ, NE | 1 |
| Kasumov, ChM | 1 |
| Durnov, LA | 1 |
| Siu, LL | 1 |
| Moore, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Observational Study on the Treatment of Patients With Localized Osteosarcoma[NCT04890067] | 120 participants (Anticipated) | Observational | 2021-07-30 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ifosfamide and Kidney Failure
| Article | Year |
|---|---|
Management and outcomes in children with lupus nephritis in the developing countries.
Topics: Child; Developing Countries; Humans; Ifosfamide; Lupus Nephritis; Renal Dialysis; Renal Insufficienc | 2023 |
Ifosfamide in the treatment of bladder cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo | 1996 |
Use of mesna to prevent ifosfamide-induced urotoxicity.
Topics: Antineoplastic Agents, Alkylating; Drug Administration Schedule; Humans; Ifosfamide; Kidney; Mesna; | 1998 |
1 trial available for ifosfamide and Kidney Failure
| Article | Year |
|---|---|
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Pre | 2005 |
5 other studies available for ifosfamide and Kidney Failure
| Article | Year |
|---|---|
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Mitochondrial Transplantation Therapy against Ifosfamide Induced Toxicity on Rat Renal Proximal Tubular Cells.
Topics: Animals; Glutathione; Ifosfamide; Kidney; Kidney Tubules, Proximal; Lipid Peroxidation; Membrane Pot | 2023 |
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendo | 2015 |
Electrolyte abnormalities and progressive renal failure in a cancer patient.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biopsy; C | 2007 |
Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dactinomycin; Do | 2008 |
[Biochemical parameters in the diagnosis of nephrotoxicity of antineoplastic chemotherapy in children].
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Cispl | 1997 |